Vestal Point Capital, LP CRNX Holdings History
Vestal Point Capital, LP's Crinetics Pharmaceuticals Inc Holding Summary
As of 2025-03-31, Vestal Point Capital, LP held 1.50 Mil shares of Crinetics Pharmaceuticals Inc(CRNX), totaling $50.31 Mil. This investment constitutes 3.59% of their stock portfolio, and Vestal Point Capital, LP now holds 1.6% of the outstanding Crinetics Pharmaceuticals Inc(CRNX) stock.
The initial trade took place in 2023Q4. And since then Vestal Point Capital, LP has made 2 purchases of CRNX, at an average price of $37.31, for a total of 2.15 Mil shares. In addition, there have been 2 sales at an average price of $44.41 for 655,000.00 shares. Based on historical transaction data and CRNX's current price of $30.04, Vestal Point Capital, LP's estimated gain on his CRNX holdings is $-6.25 Mil, reflecting a -7.77% gain to date.
Vestal Point Capital, LP CRNX ($30.04) Holding Chart
Vestal Point Capital, LP CRNX ($30.04) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
